Felix A. Khin-Maung-Gyi, PharmD, MBA, CIP, RAC, an active and valued leader in the field of human subjects protections and proud family man, passed away on October 2, 2014.
A pharmacist by training, Dr. Gyi received a bachelor’s degree in pharmacy from the University of Maryland School of Pharmacy in 1983, and went on to receive his doctorate in the subject from Duquesne University in 1986. He also obtained a master’s in business administration from Loyola University Maryland (Read more
by Megan Frame, Membership Coordinator
Welcome to another installment of our featured member interviews where we introduce you to our members—individuals who work to advance ethical research on a daily basis. Please read on to learn more about their professional experiences, how membership helps connect them to a larger community, and what goes on behind-the-scenes in their lives!
Today we’d like to introduce you to Steven “Steve” O’Geary, assistant vice president [...] Read more
by Meryn Robinson, Educational Program Intern
When reviewing a study that sought to investigate how sex offenders used networked technologies and communications for human trafficking, Hila Berger, MPH, CIP, and her colleagues on the IRB at Montclair State University faced a unique challenge: balancing protections for the study’s subjects—sex offenders—against protections for potential victims. The potential for subjects to incriminate themselves and potential legal obligations related to information disclosed during the research further complicated the protocol review. To overcome these challenges, the IRB and legal counsel worked together to implement additional protections for the group.
by Holly Fernandez Lynch, JD, MBioethics, Executive Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
The current framework for the regulation of human subjects research emerged largely in reaction to the horrors of Nazi human experimentation, revealed at the Nuremburg trials, and the US Public Health Service Syphilis Study at Tuskegee, conducted by US government researchers from 1932 to 1972. This [...] Read more
by Avery Avrakotos, Education and Policy Manager
PRIM&R has long been committed to the protection of the rights and welfare of human subjects, and strongly believes that informed consent is an essential mechanism for providing potential subjects with the information they need to make considered, autonomous decisions about research participation.
In July, the US Food and Drug Administration (FDA) announced it [...] Read more